Unaudited Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net loss	$ (10,980,889)	$ (3,026,904)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock compensation expense	3,995,609
Settlement of debt	200,333
Interest expense - amortization of debt discount	1,253,086
Noncash operating lease	(28,081)	10,192
Changes in fair value of derivative liability	18,693
Asset impairment loss	434,475
Depreciation	215,522	184,554
Changes in operating assets and liabilities:
Increase in accounts receivable	(80,150)	(19,871)
Increase in inventory	(31,047)	(66,543)
Decrease (increase) in prepaid expense and other assets	192,663	(478,098)
Increase (decrease) in accounts payable	184,758	(137,277)
Increase (decrease) in accrued liabilities, net	(239,684)	214,277
Increase in deferred revenue	70,000
Net cash used in operating activities	(4,794,712)	(3,319,670)
Cash flows from investing activities:
Acquisition of property and equipment	(85,499)	(641,059)
Proceeds from sale of assets	275,000
Net cash provided by (used in) investing activities	189,501	(641,059)
Cash flows from financing activities:
Proceeds from issuance of common stock	100,000	4,879,979
Proceeds from common stock issuable	610,000
Net borrowings from loan payable to financial institutions	20,864	(1,029,147)
Net borrowings on loan payable to others	21,954	186,786
Repayment of borrowings from shareholder		(100,000)
Net borrowings from convertible notes payable	3,749,999
Repayment of loan payable, PPP	(11,776)	(35,327)
Net cash provided by financing activities	4,491,041	3,902,291
Net increase (decrease) in cash and cash equivalents	(114,170)	(58,438)
Cash and cash equivalents at beginning of period	158,215	164,301
Cash and cash equivalents at end of period	44,045	105,863
Supplemental disclosure of cash flow information:
Interest	$ 150,710	$ 134,781